True North Therapeutics truenorthrx.com


Public list: Smart Money VCs (6326) Pharma Startups (6570) Rare Diseases (230)

True North Therapeutics is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of first-in-class product candidates for complement-mediated diseases. The company's lead product candidate, TNT009, is designed to selectively inhibit a target in the classical complement pathway. True North's antibody drug development is focused on the treatment of certain rare diseases mediated by the complement system.

True North Therapeutics is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of first-in-class product candidates for complement-mediated diseases. The company's lead product candidate, TNT009, is...Show all

Company (Acquired)

All investors data 15 Investors

Phone: 650-872-4700

Fax:

951 Gateway Blvd

 South San Francisco, 94080
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
True North Therapeutics $142M May 23, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related True North Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 15 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-complement c1s antibodies and uses thereof Dec 20, 2016 Oct 29, 2019 Patent
Anti-complement c1s antibodies and uses thereof Dec 20, 2016 Oct 22, 2019 Patent
Anti-complement c1s antibodies and uses thereof Nov 04, 2015 Feb 07, 2017 Patent
Anti-complement c1s antibodies and uses thereof Apr 21, 2015 Feb 07, 2017 Patent
Anti-complement c1s antibodies and uses thereof May 11, 2015 Dec 06, 2016 Patent
See all 11 patents